Expression of vitamin D receptor (VDR) in HL-60 cells is differentially regulated during the process of differentiation induced by phorbol ester, retinoic acid or interferon-gamma.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 9744516)

Published in J Steroid Biochem Mol Biol on August 01, 1998

Authors

M A Folgueira1, M H Federico, M L Katayama, M R Silva, M M Brentani

Author Affiliations

1: Disciplina de Oncologia, Departamento de Radiologia, Faculdade de Medicina da Universidade de São Paulo, Brasil.

Associated clinical trials:

Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation | NCT00926315

Articles citing this

Effects of vitamin D on the growth of normal and malignant B-cell progenitors. Clin Exp Immunol (2001) 0.78

Articles by these authors

ANTAGONISM BETWEEN HEPARIN AND PLASMA TRYPSIN. Science (1945) 2.30

[The role of echocardiography in intensive care]. Rev Port Cardiol (1995) 1.41

Myelodysplastic syndromes (MDS): prognostic factors and scoring systems. Sao Paulo Med J (1998) 1.40

Competence of the human host as a reservoir for Leishmania chagasi. J Infect Dis (2000) 1.21

Steroid receptors in pulmonary lymphangiomyomatosis. Chest (1984) 1.11

Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations. Clin Exp Metastasis (1998) 1.09

Expression of a novel factor, com1, in early tumor progression of breast cancer. Clin Cancer Res (2000) 1.02

Enterovirus isolation from foetal and placental tissues. Acta Virol (1990) 1.00

Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol (2001) 0.98

Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas. Braz J Med Biol Res (2009) 0.98

Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol (1996) 0.96

Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance. Dis Colon Rectum (1992) 0.95

Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res (2005) 0.95

Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer (1994) 0.94

Independent prognostic value of laminin receptor expression in breast cancer survival. Cancer Res (1990) 0.94

Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach. Int J Cancer (1986) 0.93

Steroid receptors in breast angiosarcoma. Cancer (1983) 0.89

Interstitial nephritis in human kala-azar. Trans R Soc Trop Med Hyg (1983) 0.89

Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Braz J Med Biol Res (2010) 0.89

Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors. Oncology (1993) 0.88

Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis. Int J Biol Markers (2001) 0.88

Assessment of maturity degree of composts from domestic solid wastes by fluorescence and Fourier transform infrared spectroscopies. J Agric Food Chem (2001) 0.88

Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology (1995) 0.88

Antinociceptive action of bradykinin and related kinins of larger molecular weights by the intraventricular route. Br J Pharmacol (1973) 0.87

Iron-induced esophageal ulceration. Endoscopy (2007) 0.87

Effects of the green algae Chlorella vulgaris on the response of the host hematopoietic system to intraperitoneal ehrlich ascites tumor transplantation in mice. Immunopharmacol Immunotoxicol (2001) 0.86

Hypothalamic component in pressor response to carotid occlusion in the rat. Am J Physiol (1977) 0.85

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review. Braz J Med Biol Res (2002) 0.85

Bancroftian filariasis in two urban areas of Recife, Brazil: pre-control observations on infection and disease. Trans R Soc Trop Med Hyg (1995) 0.84

Is early diagnosis of hypertension a function of cuff width? J Hypertens Suppl (1989) 0.84

Effects of androgens on proliferation and progesterone receptor levels in T47D human breast cancer cells. Tumour Biol (1993) 0.84

Vitamin D3 receptor (VDR) expression in HC-11 mammary cells: regulation by growth-modulatory agents, differentiation, and Ha-ras transformation. Breast Cancer Res Treat (1999) 0.83

Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa. Head Neck (2001) 0.83

Role of the extracellular matrix in variations of invasive pathways in lung cancers. Braz J Med Biol Res (2013) 0.83

Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas. Cancer Detect Prev (2004) 0.83

Expression of growth factors, proto-oncogenes, and p53 in nasopharyngeal angiofibromas. Laryngoscope (1996) 0.82

Vitamin D receptor polymorphisms and prostate cancer risk in Brazilian men. Int J Biol Markers (2004) 0.82

c-erbB-2 DNA amplification and mRNA expression in human primary breast tumors and its relationship to other prognostic factors. Cancer Biother (1993) 0.81

Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine. J Endocrinol Invest (2008) 0.81

Steroid receptors in cystosarcoma phyllodes. Cancer Detect Prev (1982) 0.81

Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features. Int J Cancer (1994) 0.81

The Olmsted syndrome. Int J Dermatol (1997) 0.81

Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in T 47D breast cancer cells. J Steroid Biochem Mol Biol (1993) 0.81

Gene expression profiles in breast cancer to identify estrogen receptor target genes. Mini Rev Med Chem (2008) 0.81

Paracoccidioidomycosis associated with human immunodeficiency virus infection. Report of 10 cases. Med Mycol (2003) 0.81

Vasopressin release by antagonists of GABA and glycine [proceedings]. Br J Pharmacol (1977) 0.81

Prognosis related to staging systems for chronic lymphocytic leukemia. Sao Paulo Med J (2000) 0.81

Estrogen control of lactate dehydrogenase isoenzyme-5 in human breast cancer. Int J Cancer (1988) 0.81

Occurrence of H2-receptors for histamine in the guinea-pig intestine. Biochem Pharmacol (1975) 0.80

Steroid hormone receptors in male breast diseases. Anticancer Res (1987) 0.80

Human breast tumor slices: a model for identification of vitamin D regulated genes in the tumor microenvironment. J Steroid Biochem Mol Biol (2010) 0.80

Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer. Oncol Rep (2011) 0.80

Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients. Br J Cancer (1994) 0.80

Eosinophil accumulation in rat uterus following estradiol administration is modulated by laminin and its integrin receptors. Cell Adhes Commun (1998) 0.79

Multiple laminin receptors--a radioligand binding approach. Mem Inst Oswaldo Cruz (1991) 0.79

Characterization of a Trypanosoma cruzi strain isolated from a non-endemic area in northeast Brazil. Rev Inst Med Trop Sao Paulo (1995) 0.79

Human semaphorin 6B [(HSA)SEMA6B], a novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic acid-dependent downregulation in glioblastoma cell lines. Genomics (2001) 0.79

Risk factors for the occurrence of bancroftian filariasis infection in children living in endemic areas of northeast of Brazil. J Trop Pediatr (1998) 0.79

Carcinoembryonic antigen (CEA): production of immunoprecipitating monoclonal antibodies and development of an enzyme immunoassay. Hybridoma (1987) 0.79

Genetic alterations in Ki-ras and Ha-ras genes in juvenile nasopharyngeal angiofibromas and head and neck cancer. Sao Paulo Med J (1999) 0.79

Elastosis and steroid receptors in primary breast cancer. Braz J Med Biol Res (1985) 0.78

Homozygous Hb Stanleyville-II [alpha2 78(EF7) Asn>Lys; HBA2:c.237C>A, not C>G] associated with genotype -α 3.7/-α 3.7 in two Brazilian families. Int J Lab Hematol (2011) 0.78

Plasminogen activator expression and steroid hormone receptors in female breast cancer: a multifactorial study. Int J Cancer (1988) 0.78

Direct evidence for projectile charge-state dependent crater formation due to fast ions. Phys Rev Lett (2008) 0.78

Steroid receptors in a group of Brazilian breast cancer patients. J Surg Oncol (1981) 0.78

Lactate dehydrogenase in breast carcinoma: correlation with estrogen and progesterone receptors. Cancer Detect Prev (1983) 0.77

Steroid receptors in intracranial tumors. Clin Neuropharmacol (1984) 0.77

Differential regulation of vitamin D receptor expression in distinct leukemic cell lines upon phorbol ester-induced growth arrest. Braz J Med Biol Res (2000) 0.77

Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes. Cancer (1986) 0.77

Nutrition and acute schistosomiasis. Mem Inst Oswaldo Cruz (1992) 0.77

[Biliary microcrystals in idiopathic acute pancreatitis: clue for occult underlying biliary etiology]. Arq Gastroenterol (2000) 0.77

Glucocorticoid receptor in active pulmonary sarcoidosis. Sarcoidosis (1990) 0.77

The effects of ras gene expression on glucocorticoid receptors in mouse fibroblasts. J Steroid Biochem Mol Biol (1990) 0.77

A strange duodenal lesion. Rev Esp Enferm Dig (2010) 0.77

Occupied and unoccupied type II estrogen binding sites in human breast cancer. J Steroid Biochem (1987) 0.77

Prognostic factors in non-Hodgkin lymphomas. Sao Paulo Med J (2000) 0.77

Tissue carcinoembryonic antigen and estrogen receptor in human breast cancer. Int J Cancer (1985) 0.77

Repression of glucocorticoid receptor gene transcription by c-Jun. Mol Cell Endocrinol (2001) 0.77

Retention and multilineage expression of human hematopoietic stem cells in human-sheep chimeras. Blood Cells (1994) 0.76

Expression of c-erbB-2, p53 and c-myc proteins in male breast carcinoma: Comparison with traditional prognostic factors and survival. Braz J Med Biol Res (2001) 0.76

Gene expression profiling of clinical stages II and III breast cancer. Braz J Med Biol Res (2006) 0.76

Large-volume leukaphereses may be more efficient than standard-volume leukaphereses for collection of peripheral blood progenitor cells. J Hematother (1997) 0.76

Chronic myeloid leukemia (CML): prognostic factors and survival analysis. Sao Paulo Med J (1997) 0.76

Glucocorticoid receptors in subpopulations of human lymphocytes defined by monoclonal antibodies. Cell Immunol (1987) 0.76

Effects of steroids on laminin-binding integrins in a human melanoma cell line. Int J Cancer (1991) 0.76

Regulation of the glucocorticoid receptor by glucocorticoids in human mononuclear leukocytes. Horm Res (1986) 0.76

Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma. Braz J Med Biol Res (2002) 0.76

Glucocorticoid receptors in acute leukemia. Braz J Med Biol Res (1986) 0.76

Effect of pharmacological purging on natural killer cell number and activity in human bone marrow. Clin Immunol Immunopathol (1992) 0.76

Adult respiratory distress syndrome: evidence of early fibrogenesis and absence of glucocorticoid receptors. Eur J Respir Dis (1986) 0.76

Laminin and estradiol regulation of the plasminogen-activator system in MCF-7 breast-carcinoma cells. Int J Cancer (1998) 0.75

Cytokeratin 20 is not a reliable molecular marker for occult breast cancer cell detection in hematological tissues. Breast Cancer Res Treat (2001) 0.75

Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex. Br J Cancer (1995) 0.75

Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing peptide-6: studies in normal men and in patients with adrenal insufficiency. J Clin Endocrinol Metab (2000) 0.75